Literature DB >> 19106403

Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases.

William R Hiatt, Jerry Goldstone, Sidney C Smith, Mary McDermott, Gregory Moneta, Roberta Oka, Anne B Newman, William H Pearce.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 19106403     DOI： 10.1161/CIRCULATIONAHA.108.191171

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  33 in total

1.  Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England.

Authors:  Meghan Dermody; Christopher Homsy; Yuanyuan Zhao; Philip P Goodney; James M Estes
Journal:  J Vasc Surg       Date:  2015-05-04       Impact factor: 4.268

2.  Getting A Leg Up on Cell Therapy for Critical Limb Ischemia.

Authors:  S Keisin Wang; Michael P Murphy
Journal:  Circ Res       Date:  2017-04-14       Impact factor: 17.367

3.  Association between lifestyles, anthropometric measurements and peripheral arterial disease in public sector health workers.

Authors:  Janett V Chávez-Sosa; Ricardo Rojas-Humpire; Rosmery Gutierrez-Ajalcriña; Salomón Huancahuire-Vega
Journal:  Am J Cardiovasc Dis       Date:  2021-04-15

4.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).

Authors:  Karen A Hicks; James E Tcheng; Biykem Bozkurt; Bernard R Chaitman; Donald E Cutlip; Andrew Farb; Gregg C Fonarow; Jeffrey P Jacobs; Michael R Jaff; Judith H Lichtman; Marian C Limacher; Kenneth W Mahaffey; Roxana Mehran; Steven E Nissen; Eric E Smith; Shari L Targum
Journal:  J Nucl Cardiol       Date:  2015-10       Impact factor: 5.952

Review 5.  Neutrophil-to-lymphocyte ratio in occlusive vascular diseases: the literature review of the past 10 years.

Authors:  Egemen Küçük; İbrahim Kocayiğit; Candan Günel; Hasan Düzenli
Journal:  World J Emerg Med       Date:  2016

Review 6.  Primary and Novel Lipid-Lowering Therapies to Reduce Risk in Patients With Peripheral Arterial Disease.

Authors:  Alicia Chionchio; Andrew Galmer; Benjamin Hirsh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-12-17

7.  Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).

Authors:  Manesh R Patel; Michael S Conte; Donald E Cutlip; Nabil Dib; Patrick Geraghty; William Gray; William R Hiatt; Mami Ho; Koji Ikeda; Fumiaki Ikeno; Michael R Jaff; W Schuyler Jones; Masayuki Kawahara; Robert A Lookstein; Roxana Mehran; Sanjay Misra; Lars Norgren; Jeffrey W Olin; Thomas J Povsic; Kenneth Rosenfield; John Rundback; Fadi Shamoun; James Tcheng; Thomas T Tsai; Yuka Suzuki; Pascal Vranckx; Bret N Wiechmann; Christopher J White; Hiroyoshi Yokoi; Mitchell W Krucoff
Journal:  J Am Coll Cardiol       Date:  2015-03-10       Impact factor: 24.094

Review 8.  Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities.

Authors:  Cintia B Ueta; Katia S Gomes; Márcio A Ribeiro; Daria Mochly-Rosen; Julio C B Ferreira
Journal:  Pharmacol Res       Date:  2016-11-19       Impact factor: 7.658

9.  Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.

Authors:  Anthony A Bavry; R David Anderson; Yan Gong; Scott J Denardo; Rhonda M Cooper-Dehoff; Eileen M Handberg; Carl J Pepine
Journal:  Hypertension       Date:  2009-12-07       Impact factor: 10.190

Review 10.  Intermittent claudication: new targets for drug development.

Authors:  Eric P Brass
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.